MedTrace Logo

The Efficacy of Amway Herbal Drink to Improve Skin Anti-aging

NCT05986799 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-08-14

No results posted yet for this study

Summary

This goal of this two arms, randomized, double-blind controlled trial is to study whether Amway herbal drink could improve skin anti-aging in the middle-aged people of 30-60 years old. The main questions it aims to answer are:

1. whether skin elasticity will be improved measured by Cutometer
2. whether skin wrinkles/roughness/pores will be improved measured by Antera 3D

30 eligible Participants will be enrolled in one center and randomly assigned to two study groups (Amway herbal drink group and placebo drink group). Up to four study visits will be made by the subject over a 3-month period intervention and all clinical data will be captured and recorded into CTMS (Clinical Trial Management System) for data analysis and reporting.

Researchers will compare Amway herbal drink group and placebo drink group to see if consumption of Amway herbal drink could significantly improve skin anti-aging at the end of the study.

Conditions

  • Skin Laxity
  • Skin Lines

Interventions

DIETARY_SUPPLEMENT

Amway Herbal Drink

1 sachet per time, 3 times daily, for 3 months period.

DIETARY_SUPPLEMENT

Placebo Drink

1 sachet per time, 3 times daily, for 3 months period.

Sponsors & Collaborators

  • Amway (China) R&D Center

    lead INDUSTRY

Principal Investigators

  • Yun Wang, MD · Shanghai Jiao Tong University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-13
Primary Completion
2023-11-15
Completion
2023-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05986799 on ClinicalTrials.gov